India–EU Free Trade Agreement: Unlocking Growth in Semiconductors and Pharmaceutical

India and the European Union have just signed their largest-ever free trade agreement, covering nearly two billion people and a quarter of global GDP. This deal slashes tariffs, opens markets, and creates new opportunities for industries like semiconductors and pharmaceuticals, where India is rapidly expanding and the EU seeks diversified supply chains. 

Why the India–EU Free Trade Agreement Matters

• Scale: Covers €180 billion in annual trade and supports nearly 800,000 EU jobs.

• Tariff Reductions: Eliminates duties on most goods, including advanced manufacturing inputs.

• Market Access: Opens services, agriculture, and industrial sectors to freer exchange.

• Strategic Timing: Signed amid global supply chain realignments and geopolitical tensions.

Impact on the Semiconductor Industry

• Diversified Supply Chains: EU companies gain access to India’s growing chip design and assembly ecosystem, reducing reliance on East Asia.

• Investment Incentives: Lower tariffs on equipment imports (e.g., wafer loaders, test handlers, chambers) make it easier to set up fabs in India.

• Collaboration Opportunities: Indian firms can partner with European leaders in automation and testing, leveraging equipment from companies like Mirae (South Korea), Medec (Japan), and MSL (Italy) to strengthen production floors.

• AI & Data Demand: With Micron and other global players expanding in Asia, India’s integration with EU markets accelerates semiconductor adoption.

Impact on the Pharmaceutical Industry

• Export Growth: India, already the “pharmacy of the world,” gains easier access to EU markets for generics, vaccines, and APIs.

• Joint R&D: EU pharma firms can collaborate with Indian companies on vaccine development and biotech innovation.

• Regulatory Alignment: Simplified procedures reduce barriers for clinical trials and drug approvals.

• Public Health Security: Outbreaks like Nipah highlight the importance of pharma partnerships; the FTA strengthens resilience by ensuring faster distribution of medicines across continents.